ACEs, SIRT1, and Premature Vascular Aging in Humans

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 27, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions
Adverse Childhood ExperiencesEndothelial Dysfunction
Interventions
DIETARY_SUPPLEMENT

Nicotinamide Riboside

Participants will consume 1,000 mg of nicotinamide riboside (NR) upon waking and with an evening meal, and complete a daily supplementation log to assist with compliance monitoring. NR is a naturally occurring vitamin B3 derivative readily taken up by cells as a direct NAD+ precursor. Similar NR supplementation protocols are well-tolerated, boost NAD+ concentrations by \~100-140% achieving a steady state within 1-2 weeks, and increase SIRT activity in humans.

DIETARY_SUPPLEMENT

Placebo

Participants will consume 1,000 mg of placebo (microcrystalline cellulose) upon waking and with an evening meal, and complete a daily supplementation log to assist with compliance monitoring.

Trial Locations (1)

52242

RECRUITING

Integrative Laboratory of Applied Physiology and Lifestyle Medicine, Iowa City

All Listed Sponsors
lead

Nathaniel Jenkins

OTHER